Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.01)
%-0.35
Latest2.85
High3.02
Low2.80
Volume144,999
Turnover (SEK)414,913
Market Cap (MSEK)152

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:08 PMNONMLI2.85370
5:04 PMNONMLI2.85600
4:44 PMAVAMLI2.85100
4:26 PMNONAVA2.821,000
4:26 PMNONAVA2.82635
4:26 PMAVAAVA2.821,000
4:24 PMNONAVA2.832,474
4:24 PMAVAAVA2.831,230
4:19 PMNONNON2.863,500
3:26 PMAVAMLI2.885,000

Scheduled Reports

DateReport
2017-11-10Extra bolagsstämma
2017-11-18Delårsrapport ett
2017-12-14Årsstämma




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se